Zobrazeno 1 - 10
of 30
pro vyhledávání: '"Konrad Schwarzkopf"'
Autor:
Benedikt Huck, Alberto Hidalgo, Franziska Waldow, Dominik Schwudke, Karoline I. Gaede, Claus Feldmann, Patrick Carius, Chiara Autilio, Jesus Pérez-Gil, Konrad Schwarzkopf, Xabier Murgia, Brigitta Loretz, Claus-Michael Lehr
Publikováno v:
Small Science, Vol 1, Iss 12, Pp n/a-n/a (2021)
The interplay of particles with pulmonary surfactant, a lipid‐protein material pivotal for lung function, is hypothesized as a key factor that has not been routinely considered in the current in vitro models when determining the fate of inhaled nan
Externí odkaz:
https://doaj.org/article/9bbd7c9cd0c448ae95b5eb07a31d19ef
Autor:
Nashrawan Lababidi, Valentin Sigal, Aljoscha Koenneke, Konrad Schwarzkopf, Andreas Manz, Marc Schneider
Publikováno v:
Beilstein Journal of Nanotechnology, Vol 10, Iss 1, Pp 2280-2293 (2019)
Great challenges still remain to develop drug carriers able to penetrate biological barriers (such as the dense mucus in cystic fibrosis) and for the treatment of bacteria residing in biofilms, embedded in mucus. Drug carrier systems such as nanopart
Externí odkaz:
https://doaj.org/article/6831b99672454e17a6a961e35e4e2717
Autor:
Florian Setzer, Barbara Schmidt, Lars Hueter, Konrad Schwarzkopf, Jörg Sänger, Torsten Schreiber
Publikováno v:
PLoS ONE, Vol 13, Iss 6, p e0198440 (2018)
BACKGROUND:Aspiration of gastric acid is an important cause of acute lung injury. The time course of the pulmonary response to such an insult beyond the initial 48 hours is incompletely characterized. The purpose of this study was to comprehensively
Externí odkaz:
https://doaj.org/article/9ae04425e2684ca6b3a7319bf58e71b9
Autor:
Hendrik Bracht, Andreas Meiser, Jan Wallenborn, Ulf Guenther, Klaus M. Kogelmann, Andreas Faltlhauser, Konrad Schwarzkopf, Jens Soukup, Tobias Becher, Patrick Kellner, Rihard Knafelj, Peter Sackey, Martin Bellgardt
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::863e4fc166a6ffd7afc11f75202f632b
https://doi.org/10.2139/ssrn.4358415
https://doi.org/10.2139/ssrn.4358415
Autor:
Christian Herr, Dominic Eisinger, Thomas Volk, Guy Danziger, Sabrina I. Hörsch, Michael Kindermann, Sigrun Smola, Robert Bals, Bahareh Mozafari, Martina Seibert, Florian Custodis, Daniel Grandt, Philipp M. Lepper, Sanjay Kumar Srikakulam, Constantin Marcu, Konrad Schwarzkopf, Rolf Müller, Marcin Krawczyk, Zuhair Wolf Dietrich Ataya, Harald Schäfer, Gudrun Wagenpfeil, Felix Ritzmann, Kai Eltges, Frank Lammert, Katharina Günther, Thimoteus Speer, Marc Mittag, Andreas Keller, Christoph Beisswenger, Thomas Adams, Michael Zemlin, Sebastian Mang
Publikováno v:
Journal of Inflammation Research, Vol Volume 14, Pp 4651-4667 (2021)
Journal of inflammation research
New Zealand
Journal of Inflammation Research
Journal of inflammation research
New Zealand
Journal of Inflammation Research
Background COVID-19 comprises several severity stages ranging from oligosymptomatic disease to multi-organ failure and fatal outcomes. The mechanisms why COVID-19 is a mild disease in some patients and progresses to a severe multi-organ and often fat
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::9eaef46c60e9878a6fb2dc762074139c
Autor:
Justus C Horstmann, Annette Boese, Benedikt Huck, Konrad Schwarzkopf, Xabier Murgia, Cristiane de Souza Carvalho-Wodarz, Claus-Michael Lehr, Duy-Khiet Ho, Sarah Frisch, Brigitta Loretz
Publikováno v:
The Journal of antimicrobial chemotherapy
England
England
Background Pulmonary infections associated with Pseudomonas aeruginosa can be life-threatening for patients suffering from chronic lung diseases such as cystic fibrosis. In this scenario, the formation of biofilms embedded in a mucus layer can limit
Autor:
Benedikt C. Huck, Durairaj Thiyagarajan, Aghiad Bali, Annette Boese, Karen F. W. Besecke, Constantin Hozsa, Robert K. Gieseler, Marcus Furch, Cristiane Carvalho‐Wodarz, Franziska Waldow, Dominik Schwudke, Olga Metelkina, Alexander Titz, Hanno Huwer, Konrad Schwarzkopf, Jessica Hoppstädter, Alexandra K. Kiemer, Marcus Koch, Brigitta Loretz, Claus‐Michael Lehr
Publikováno v:
Advanced healthcare materials. 11(11)
Nontuberculous mycobacterial infections rapidly emerge and demand potent medications to cope with resistance. In this context, targeted loco-regional delivery of aerosol medicines to the lungs is an advantage. However, sufficient antibiotic delivery
Autor:
Ulrich Laufs, Konrad Schwarzkopf, Michael Böhm, Florian Custodis, Rosemarie Weimann, Elmar Spüntrup
Publikováno v:
Clinical Research in Cardiology
Autor:
Marc Schneider, Valentin Sigal, Konrad Schwarzkopf, Aljoscha Koenneke, Andreas Manz, Nashrawan Lababidi
Publikováno v:
Beilstein Journal of Nanotechnology
Beilstein Journal of Nanotechnology, Vol 10, Iss 1, Pp 2280-2293 (2019)
Beilstein Journal of Nanotechnology, Vol 10, Iss 1, Pp 2280-2293 (2019)
Great challenges still remain to develop drug carriers able to penetrate biological barriers (such as the dense mucus in cystic fibrosis) and for the treatment of bacteria residing in biofilms, embedded in mucus. Drug carrier systems such as nanopart
Autor:
Andreas Meiser, Thomas Volk, Jan Wallenborn, Ulf Guenther, Tobias Becher, Hendrik Bracht, Konrad Schwarzkopf, Rihard Knafelj, Andreas Faltlhauser, Serge C Thal, Jens Soukup, Patrick Kellner, Matthias Drüner, Heike Vogelsang, Martin Bellgardt, Peter Sackey, Eberhard Barth, Berthold Bein, Paul Biever, Ralph Bogdanski, Sebastian Brandt, Anreas Faltlhauser, Arnim Geise, Adrian Iustin Georgevici, Philipp Gude, Uwe Hamsen, Christian Hönemann, Kerstin Kellner, Azzeddine Kermad, Klaus Kogelmann, Rainer Kram, Andrej Markota, Werner Meermeier, Matej Podbregar, Patrick Schramm, Matthias Schroeder, Christian Waydhas, Norbert Weiler, Richard Wetzold
Publikováno v:
The Lancet. Respiratory medicine. 9(11)
Summary Background Previous studies indicate that isoflurane could be useful for the sedation of patients in the intensive care unit (ICU), but prospective studies evaluating isoflurane's efficacy have been small. The aim of this study was to test wh